Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00071175 · ClinicalTrials.gov registry record
Lupus Genetics Studies
A clinical trial, sponsored by Oklahoma Medical Research Foundation.
- Completed
- Registry status
- 3,460
- Enrollment target
NCT00071175: Completed study, sponsored by Oklahoma Medical Research Foundation.
NCT00071175 is a clinical trial that has completed, run by Oklahoma Medical Research Foundation. The registered enrollment target is 3,460 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00071175 has completed, sponsored by Oklahoma Medical Research Foundation.
- COMPLETED
- Registry status
- 3,460 participants
- Enrollment target
Study Summary
The Lupus Genetics Studies and Lupus Family Registry \& Repository are working to find the genes that reveal the causes of systemic lupus erythematosus (SLE, or lupus). The study is enrolling families of all ethnic backgrounds from the United States, Canada, Puerto Rico, and the Virgin Islands that have one or more living members diagnosed with SLE.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,460 participants |
| Start Date | 1995-10 |
| Est. Completion | 2013-11 |
What the finished NCT00071175 record still lists
NCT00071175 is an observational study that tracks outcomes without assigning an intervention. Its 3,460 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00071175 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00071175 about?
NCT00071175 is a clinical study titled "Lupus Genetics Studies". The Lupus Genetics Studies and Lupus Family Registry \& Repository are working to find the genes that reveal the causes of systemic lupus erythematosus (SLE, or lupus). The study is enrolling families of all ethnic backgrounds from the United States, Canada, Puerto Rico, and the Virgin Islands that ...
What is the current status of trial NCT00071175?
This trial is currently completed. The enrollment target is 3,460 participants. The study started on 1995-10. Estimated completion is 2013-11.
Who is sponsoring clinical trial NCT00071175?
This trial is sponsored by Oklahoma Medical Research Foundation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia